Author： Farhadi Ashkan Bruninga Keith Fields Jeremy Keshavarzian Ali
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.7, 2001-07, pp. : 1211-1222
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Irritable Bowel Syndrome: Recent and Novel Therapeutic Approaches
By Andresen Viola Camilleri Michael
Drugs, Vol. 66, Iss. 8, 2006-01 ,pp. :
CRF1 Receptors as a Therapeutic Target for Irritable Bowel Syndrome
Current Pharmaceutical Design, Vol. 12, Iss. 31, 2006-01 ,pp. :
Alosetron and irritable bowel syndrome
By Mayer Emeran A Bradesi Sylvie
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. :